Acadian Asset Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,695
| Closed | -$176K | – | 1941 |
|
|
2024
Q1 | $176K | Hold |
20,695
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q4 | $72K | Buy |
+20,695
| New | +$72K | ﹤0.01% | 1409 |
|
|
2022
Q1 | – | Sell |
-1,026
| Closed | -$55K | – | 1855 |
|
|
2021
Q4 | $55K | Buy |
1,026
+322
| +46% | +$17.3K | ﹤0.01% | 1473 |
|
|
2021
Q3 | $53K | Sell |
704
-970
| -58% | -$73K | ﹤0.01% | 1545 |
|
|
2021
Q2 | $217K | Buy |
1,674
+474
| +40% | +$61.4K | ﹤0.01% | 1414 |
|
|
2021
Q1 | $197K | Buy |
+1,200
| New | +$197K | ﹤0.01% | 1509 |
|
|
2018
Q4 | – | Sell |
-30
| Closed | -$12K | – | 1863 |
|
|
2018
Q3 | $12K | Hold |
30
| – | – | ﹤0.01% | 1546 |
|
|
2018
Q2 | $16K | Sell |
30
-2
| -6% | -$1.07K | ﹤0.01% | 1548 |
|
|
2018
Q1 | $15K | Buy |
+32
| New | +$15K | ﹤0.01% | 1518 |
|